Phathom Pharmaceuticals (PHAT) is a good biotech to keep an eye on in the coming months because it is gearing up to potentially receive an expanded FDA approval of its drug Voquenza as a daily ...
VOQUEZNA TRIPLE and DUAL PAKs each contain vonoprazan, a novel, first-in-class potassium-competitive acid blocker (PCAB), and have demonstrated superior eradication rates vs. lansoprazole-based triple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results